Stock·NYSE·Basic Materials
Ecolab Inc. (ECL)
- Market cap
- $80.98B
- P/E
- 39.03
- Dividend yield
- 1.01%
- Street target
- $330.00median of 24 analysts
- 52-week range
- $243.15 $309.27
The short version
Where ECL stands today, in four lines, and what CleaRank Financial AI makes of it.
ECL at a glance
Ecolab Inc. (ECL): Buy, 66/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($279.73 and $274.81).
- Earnings ECL beat estimates in 3 of its last 7 quarters, yet fell the next day after 1 of those beats.
- Insiders Insiders sold $31.2M and bought $4.1M over the last 18 months.
- Valuation P/E of 39.0 against 30.2 for the Basic Materials sector: a premium to peers (+29%).
Figures as of October 16, 2026.
CleaRank Financial AI
Ecolab Inc. (ECL) carries a CleaRank rating of Buy and a model score of 66/100.
Trend is the largest contributor: the price sits 5.12% above its 200-day average and 3.27% above its 50-day average, and the 50-day average is 1.79% above the 200-day. Valuation is the largest drag, with a P/E of 39.03 that is 29.3% above the sector median (a premium to peers) and a P/S of 4.84 that is 15.2% above the sector median. The 50-day average is $279.73 and the 200-day average is $274.81, and over the past year the price rose 6.75%.
Only on CleaRank
Figures we compute ourselves from ECL's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $288.89 is 3.3% above the 50-day simple moving average of $279.73.Price above its 200-day average ›
The price is 5.1% above the 200-day simple moving average of $274.81.50-day average above the 200-day ›
The 50-day average ($279.73) is 1.8% above the 200-day average ($274.81), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 69% of its 52-week range, between $243.15 and $309.27.
ECL share price
Pick a period: each tab shows how far ECL has moved over it, to the last close.
Today's trading
Where ECL sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
2/5P/E below the sector median ›
The trailing P/E of 39.03 is 29.3% above the Basic Materials median of 30.2.P/S below the sector median ›
The price-to-sales ratio of 4.84 is 15.2% above the sector median of 4.2.Profitable over the last 12 months ›
Net income over the last 12 months was $2.1B on revenue of $16.8B, a net margin of 12.6%.Beat estimates in most recent reports ›
ECL beat the EPS estimate in 3 of its last 7 reports.Pays a dividend ›
The trailing dividend yield is 1.01%, or $2.92 a share a year.
Key statistics
The headline figures for ECL.
As of October 16, 2026, ECL trades at $288.89, with a market value of $80.98B, a P/E ratio of 39.03 and a dividend yield of 1.01%.
What the numbers say
CleaRank Financial AI's reading of ECL's valuation, growth and risks.
Ecolab Inc. (ECL)'s trailing P/E stands at 39.03, against a Basic Materials median of 30.2. That makes it 29.3% above the sector median P/E, and the Peer Benchmarking card reads the P/E as a premium to peers. On sales, ECL changes hands at 4.84 times, which is 15.2% above the sector median of 4.2. To put the size in context, ECL has a market capitalisation of $81.0B and trailing earnings of $7.45 per share.
ECL's revenue grew 9.70%, which is 9.3 percentage points slower than the sector median of 19.0%. Profitability is the stronger side of the story: a net margin of 12.57%, an operating margin of 18.52% and a return on equity of 21.96%, which sits above the sector median of 17.9%. On the balance sheet, debt-to-equity is 1.38, and the trailing dividend yield is 1.01%, or $2.92 a share each year.
EPS of $1.70 versus the $1.70 analysts expected made the April 28, 2026 report a miss of 0.00%. The market agreed: the stock fell 3.88% the following session.
Over its last 7 reports, ECL topped the estimate 3 times; even so, 1 of those 3 beats was followed by a lower share price the next session. Earlier, the stock fell 4.03% after the October 28, 2025 report, a miss of 0.00%. Looking ahead, analysts expect EPS of $8.16 this fiscal year (growth of 8.4%) and $9.41 the year after (growth of 15.2%).
The P/E of 39.03, 29.3% above the sector median, puts ECL at a premium to peers, so weaker results would meet a higher bar. On a typical day the price of ECL shifts by 1.02%, the 30-day standard deviation of its daily returns. Insiders sold $31.2M over the last 18 months and bought $4.1M, though sales of this kind are often planned in advance and say less than purchases would.
ECL against the Basic Materials sector
How ECL compares with the median Basic Materials stock CleaRank tracks.
Price to earnings vs sector: ECL trades at a significant premium to sector peers (+29%), suggesting market expectations for superior growth or market position.
Return vs XLB: Since May 5, 2025, ECL has gained 14.0% against a gain of 20.0% for XLB.
Performance against XLB
ECL and the Basic Materials sector fund over the same days.
Revenue and earnings
How much ECL sells, and how much of it becomes profit.
Revenue growth: Revenue grew 2.2% in FY2025 to $16.1B, from $15.7B a year earlier.
Profit margin: The net margin was 13.0% in FY2025, down from 13.5% the year before.
Profitable: ECL earned $2.1B in FY2025.
Earnings reality check
Did ECL beat what analysts expected, and how did the stock react?
Earnings record: ECL beat the analyst estimate in 3 of the last 7 quarters.
Market reaction: The stock fell in the first session after 1 of those 3 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Apr 28, 2026after close | $1.70 | $1.70 | +0.00% | -3.88% | -3.49% |
| Feb 10, 2026after close | $2.07 | $2.08 | +0.48% | +1.31% | +0.99% |
| Oct 28, 2025after close | $2.07 | $2.07 | +0.00% | -4.03% | -3.59% |
| Jul 29, 2025after close | $1.90 | $1.89 | -0.53% | +1.44% | +2.73% |
| Apr 29, 2025after close | $1.50 | $1.50 | +0.00% | +1.83% | +2.32% |
| Feb 11, 2025after close | $1.80 | $1.81 | +0.56% | +0.31% | +1.92% |
| Oct 29, 2024after close | $1.82 | $1.83 | +0.55% | -0.46% | -2.72% |
Reports after April 28, 2026 are not yet in our data.
As of October 16, 2026, ECL has beaten the analyst EPS estimate in 3 of its last 7 reported quarters and fell in the first trading session after 1 of those beats; its most recent report in our data, on April 28, 2026, came in 0.00% above the estimate and the stock moved -3.88% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 63.4, showing bullish momentum without being overbought.RSI above 50 ›
An RSI of 63.4 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank AI analysis of ECL
The score, the reasoning behind it, and what could move the price next.
Ecolab Inc. (ECL) is trading in an uptrend. The price of $288.89 sits 3.27% above its 50-day average of $279.73 and 5.12% above its 200-day average of $274.81. In its 52-week range of $243.15 to $309.27, the price is at 69% of the span, and it is 6.59% below the high.
The 14-day RSI of 63.4 is in the bullish zone, below the overbought line, and the MACD line is positive. The record is positive across every period shown: the price rose 5.89% over the past three months, rose 5.13% over the past six months and rose 6.75% over the past year. Volume in the last session ran 149.1% above its average, on a day the price fell 0.66%.
Analyst upgrade ›
Oppenheimer upgraded it to Outperform from Perform on July 17, 2026.
Source: Analyst action, Oppenheimer, July 17, 2026Rating reaffirmed ›
UBS kept its Buy rating on October 5, 2026.
Source: Analyst action, UBS, October 5, 2026
Earnings miss ›
The April 28, 2026 report missed the EPS estimate by 0.00%, and the share price fell 3.88% in the first session after it.
Source: Earnings report, April 28, 2026
- The two nearest levels matter most: the 52-week high at $309.27 sits above the price, and the 20-day EMA at $281.58 sits below it.
- With the 14-day RSI at 63.4 and the MACD line positive, ECL's momentum reads as bullish. Readings above 70 or below 30 would point to stretched momentum.
- ECL beat estimates in 3 of the last 7 reports, yet after the April 28, 2026 report the share price still fell 3.88% in the first session.
The uptrend rests on ECL staying above its 50-day average at $279.73 and its 200-day average at $274.81; a close below the 50-day would be the first crack in it. On a pullback, the first level the price would meet is the 20-day EMA at $281.58.
The next level above the price is the 52-week high at $309.27.
Technical indicators
Momentum and trend for ECL, from its daily closes.
As of October 16, 2026, with ECL at $288.89, its 14-day RSI is 63.4 (showing bullish momentum without being overbought), its 50-day simple moving average is $279.73 and its 200-day is $274.81.
Calculated by CleaRank on daily closes as of October 16, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What ECL moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 16, 2026, ECL's 1-year correlation of daily returns is +0.44 with S&P 500 (SPY), +0.30 with Nasdaq 100 (QQQ), +0.06 with Bitcoin (BTC) and +0.14 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
20 of 24 analysts rate it a buy or strong buy, 4 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $330.00 is 14.2% above the price.More buy ratings than three months ago ›
20 of 24 rate it a buy now, against 20 of 26 three months ago.
ECL Wall Street View
12-month price targets
The price, $288.89, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 5, 2026 | UBS | Maintains | Buy |
| Jul 30, 2026 | Wells Fargo | Maintains | Equal-Weight |
| Jul 29, 2026 | Mizuho | Maintains | Outperform |
| Jul 29, 2026 | BMO Capital | Maintains | Outperform |
| Jul 29, 2026 | JP Morgan | Maintains | Overweight |
| Jul 17, 2026 | Oppenheimer | Upgrade | Outperform |
As of October 16, 2026, 24 Wall Street analysts cover ECL: 20 rate it a buy or strong buy, 4 a hold and 0 a sell or strong sell. Their 12-month price targets range from $295.00 to $360.00, with a median of $330.00, 14.2% above the price of $288.89.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
ECL trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from ECL's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much ECL tends to move, against the market and on its own.
The long record
ECL's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Average daily move under 2% ›
The price has moved 1.02% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 40.3%, from December 2021 to November 2022, regained by March 2024.Most 1-year holds ended higher ›
81% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $27,837, against $42,525 in the S&P 500 (SPY).
ECL Drawdowns & Recovery
As of October 16, 2026, ECL's worst peak-to-trough fall over the last 10 years with dividends reinvested was -40.3% (December 2021 to November 2022); it regained that peak by March 2024, 16 months after the low, and 81% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into ECL in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: ECL trailed the S&P 500 over this period: $27,837 against $42,525.
A $10,000 investment in ECL in October 2016 would be worth about $27,837 today with dividends reinvested, compared with about $42,525 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to ECL, and which have not.
Strongest month, November: an average of +3.46%, up in 7 of 10 years.
Weakest month, September: an average of -2.25%, up in 3 of 10 years.
This month, October: has averaged -0.64%, up in 4 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, ECL's strongest calendar month has been November (average +3.46%, up in 7 of 10 years) and its weakest September (average -2.25%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in ECL, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in ECL today could grow to about $20,814 by 2036 in the base case, with a 90th-percentile outcome near $57,599 and a 10th-percentile outcome around $7,522. The simulation models price only; at today's 1.01% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
ECL Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $387 for ECL by 2030 in the base case, from $289 today (1.3x over 4 years). The 10th-percentile path ends near $203. These are outcomes of a Monte Carlo simulation run on ECL's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $225 | $311 | $429 | |
| 2028 | $212 | $335 | $527 | |
| 2029 | $206 | $360 | $629 | |
| 2030 | $203 | $387 | $737 | |
| 2031 | $203 | $417 | $856 |
Method: a lognormal simulation of ECL's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
ECL insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $4.1M on the open market and sold $31.2M.
As of October 16, 2026, ECL insiders reported 18 open-market sales worth $31.2M and 7 open-market purchases worth $4.1M over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 11, 2026 | Eric Mark Green
Director
|
Buy | 3.7K | $1.0M |
| Aug 18, 2026 | Christophe Beck
Chief Executive Officer
|
Sell | 17.9K | $5.0M |
| Aug 11, 2026 | Gregory B Cook
Officer
|
Sell | 4.6K | $1.3M |
| Aug 3, 2026 | Jennifer J Bradway
Officer
|
Grant | 6.5K | - |
| Jul 30, 2026 | Scott D. Kirkland
Chief Financial Officer
|
Sell | 3.4K | $929.8K |
| Jul 30, 2026 | Scott D. Kirkland
Chief Financial Officer
|
Option | 4.0K | $467.6K |
| Jun 30, 2026 | Judson Althoff
Director
|
Grant | 130 | - |
| Jun 30, 2026 | Shari L Ballard
Director
|
Grant | 260 | $36.3K |
| Jun 30, 2026 | Michel Doukeris
Director
|
Grant | 130 | - |
| Jun 30, 2026 | Eric Mark Green
Director
|
Grant | 273 | $40.0K |
| Jun 30, 2026 | Marion K Gross
Director
|
Grant | 130 | - |
| Jun 30, 2026 | Michael J Larson
Director
|
Grant | 130 | - |
| Jun 30, 2026 | David W Maclennan
Director
|
Grant | 176 | $12.8K |
| Jun 30, 2026 | Tracy B. Mckibben
Director
|
Grant | 130 | - |
| Jun 30, 2026 | Lionel L Nowell III
Director
|
Grant | 130 | - |
| Jun 30, 2026 | Suzanne M. Vautrinot
Director
|
Grant | 130 | - |
| Jun 30, 2026 | Julie Patenaude Whalen
Director
|
Grant | 130 | - |
| Jun 30, 2026 | John J Zillmer
Director
|
Grant | 130 | - |
| Jun 11, 2026 | Benjamin M. Clark
Officer
|
Buy | 1.0K | $263.8K |
| Jun 10, 2026 | Michel Doukeris
Director
|
Buy | 7.8K | $2.0M |
| Jun 9, 2026 | Darrell R Brown
Officer
|
Sell | 10.0K | $2.6M |
| Jun 9, 2026 | Darrell R Brown
Officer
|
Option | 10.0K | $1.2M |
| May 27, 2026 | Suzanne M. Vautrinot
Director
|
Sell | 1.0K | $266.0K |
| May 22, 2026 | Suzanne M. Vautrinot
Director
|
Option | 2.0K | $251.3K |
| May 13, 2026 | David W Maclennan
Director
|
Buy | 1.0K | $250.7K |
| May 4, 2026 | Gregory B Cook
Officer
|
Grant | 8.4K | - |
| May 4, 2026 | David W Maclennan
Director
|
Buy | 800 | $205.5K |
| Mar 31, 2026 | Judson Althoff
Director
|
Grant | 137 | - |
| Mar 31, 2026 | Shari L Ballard
Director
|
Grant | 275 | $36.2K |
| Mar 31, 2026 | Michel Doukeris
Director
|
Grant | 137 | - |
| Mar 31, 2026 | Eric Mark Green
Director
|
Grant | 289 | $40.0K |
| Mar 31, 2026 | Marion K Gross
Director
|
Grant | 137 | - |
| Mar 31, 2026 | Michael J Larson
Director
|
Grant | 137 | - |
| Mar 31, 2026 | David W Maclennan
Director
|
Grant | 186 | $12.8K |
| Mar 31, 2026 | Tracy B. Mckibben
Director
|
Grant | 137 | - |
| Mar 31, 2026 | Lionel L Nowell III
Director
|
Grant | 137 | - |
| Mar 31, 2026 | Victoria J Reich
Director
|
Grant | 137 | - |
| Mar 31, 2026 | Suzanne M. Vautrinot
Director
|
Grant | 137 | - |
| Mar 31, 2026 | Julie Patenaude Whalen
Director
|
Grant | 137 | - |
| Mar 31, 2026 | John J Zillmer
Director
|
Grant | 137 | - |
| Mar 27, 2026 | Michael J Larson
Director
|
Option | 2.3K | $264.7K |
| Feb 26, 2026 | Gregory B Cook
Officer
|
Sell | 3.5K | $1.1M |
| Feb 26, 2026 | Gregory B Cook
Officer
|
Option | 3.8K | $520.9K |
| Feb 25, 2026 | Tracy B. Mckibben
Director
|
Sell | 1.3K | $390.5K |
| Feb 25, 2026 | Margeaux King
Officer
|
Grant | 1.7K | - |
| Feb 25, 2026 | Tracy B. Mckibben
Director
|
Option | 2.3K | $264.7K |
| Feb 24, 2026 | Christophe Beck
Chief Executive Officer
|
Sell | 20.0K | $6.1M |
| Feb 24, 2026 | Christophe Beck
Chief Executive Officer
|
Option | 23.8K | $2.8M |
| Feb 24, 2026 | Scott D. Kirkland
Chief Financial Officer
|
Grant | 404 | - |
| Feb 18, 2026 | Nicholas J Alfano
Officer
|
Grant | 2.2K | - |
| Feb 18, 2026 | Christophe Beck
Chief Executive Officer
|
Grant | 25.4K | - |
| Feb 18, 2026 | Jandeen M Boone
General Counsel
|
Grant | 593 | - |
| Feb 18, 2026 | Jennifer J Bradway
Officer
|
Grant | 1.9K | - |
| Feb 18, 2026 | Darrell R Brown
President
|
Grant | 8.5K | - |
| Feb 18, 2026 | Gregory B Cook
Officer
|
Grant | 3.4K | - |
| Feb 18, 2026 | Boo Alexander A De
Officer
|
Grant | 2.4K | - |
| Feb 18, 2026 | Alexandra M A Hlila
Officer
|
Grant | 508 | - |
| Feb 18, 2026 | Scott D. Kirkland
Chief Financial Officer
|
Grant | 9.7K | - |
| Feb 17, 2026 | Nicholas J Alfano
Officer
|
Sell | 9.5K | $2.9M |
| Feb 17, 2026 | Nicholas J Alfano
Officer
|
Option | 9.5K | $1.3M |
| Feb 13, 2026 | Victoria J Reich
Director
|
Sell | 1.0K | $301.1K |
| Feb 13, 2026 | Jennifer J Bradway
Officer
|
Sell | 613 | $185.1K |
| Feb 13, 2026 | Jennifer J Bradway
Officer
|
Option | 950 | $130.2K |
| Feb 13, 2026 | Victoria J Reich
Director
|
Option | 1.0K | $115.1K |
| Feb 13, 2026 | John J Zillmer
Director
|
Option | 2.3K | $264.7K |
| Dec 31, 2025 | Judson Althoff
Director
|
Grant | 128 | - |
| Dec 31, 2025 | Shari L Ballard
Director
|
Grant | 256 | $33.8K |
| Dec 31, 2025 | Michel Doukeris
Director
|
Grant | 128 | - |
| Dec 31, 2025 | Eric Mark Green
Director
|
Grant | 265 | $36.3K |
| Dec 31, 2025 | Marion K Gross
Director
|
Grant | 128 | - |
| Dec 31, 2025 | Michael J Larson
Director
|
Grant | 128 | - |
| Dec 31, 2025 | David W Maclennan
Director
|
Grant | 171 | $11.6K |
| Dec 31, 2025 | Tracy B. Mckibben
Director
|
Grant | 128 | - |
| Dec 31, 2025 | Lionel L Nowell III
Director
|
Grant | 128 | - |
| Dec 31, 2025 | Victoria J Reich
Director
|
Grant | 128 | - |
| Dec 31, 2025 | Suzanne M. Vautrinot
Director
|
Grant | 128 | - |
| Dec 31, 2025 | Julie Patenaude Whalen
Director
|
Grant | 128 | - |
| Dec 31, 2025 | John J Zillmer
Director
|
Grant | 128 | - |
| Dec 8, 2025 | David W Maclennan
Director
|
Buy | 750 | $193.2K |
| Dec 4, 2025 | Harpreet Saluja
Officer
|
Grant | 1.3K | - |
| Nov 24, 2025 | Boo Alexander A De
Officer
|
Sell | 1.4K | $381.5K |
| Nov 24, 2025 | Boo Alexander A De
Officer
|
Option | 2.2K | $256.5K |
| Nov 12, 2025 | Christophe Beck
Chief Executive Officer
|
Sell | 21.7K | $5.7M |
| Nov 12, 2025 | Christophe Beck
Chief Executive Officer
|
Option | 23.1K | $2.7M |
| Nov 12, 2025 | David W Maclennan
Director
|
Option | 3.3K | $379.7K |
| Sep 30, 2025 | Judson Althoff
Director
|
Grant | 123 | - |
| Sep 30, 2025 | Shari L Ballard
Director
|
Grant | 246 | $33.8K |
| Sep 30, 2025 | Michel Doukeris
Director
|
Grant | 123 | - |
| Sep 30, 2025 | Eric Mark Green
Director
|
Grant | 255 | $36.3K |
| Sep 30, 2025 | Marion K Gross
Director
|
Grant | 123 | - |
| Sep 30, 2025 | Michael J Larson
Director
|
Grant | 123 | - |
| Sep 30, 2025 | David W Maclennan
Director
|
Grant | 165 | $11.6K |
| Sep 30, 2025 | Tracy B. Mckibben
Director
|
Grant | 123 | - |
| Sep 30, 2025 | Lionel L Nowell III
Director
|
Grant | 123 | - |
| Sep 30, 2025 | Victoria J Reich
Director
|
Grant | 123 | - |
| Sep 30, 2025 | Suzanne M. Vautrinot
Director
|
Grant | 123 | - |
| Sep 30, 2025 | Julie Patenaude Whalen
Director
|
Grant | 75 | - |
| Sep 30, 2025 | John J Zillmer
Director
|
Grant | 123 | - |
| Aug 19, 2025 | Suzanne M. Vautrinot
Director
|
Sell | 1.4K | $383.4K |
| Aug 14, 2025 | Suzanne M. Vautrinot
Director
|
Option | 2.3K | $264.7K |
| Aug 13, 2025 | Jennifer J Bradway
Officer
|
Sell | 807 | $225.4K |
| Aug 13, 2025 | Jennifer J Bradway
Officer
|
Option | 993 | $116.9K |
| Aug 13, 2025 | David W Maclennan
Director
|
Buy | 600 | $167.1K |
| Jun 30, 2025 | Judson Althoff
Director
|
Grant | 126 | - |
| Jun 30, 2025 | Shari L Ballard
Director
|
Grant | 252 | $33.8K |
| Jun 30, 2025 | Michel Doukeris
Director
|
Grant | 126 | - |
| Jun 30, 2025 | Marion K Gross
Director
|
Grant | 76 | - |
| Jun 30, 2025 | Michael J Larson
Director
|
Grant | 126 | - |
| Jun 30, 2025 | David W Maclennan
Director
|
Grant | 169 | $11.6K |
| Jun 30, 2025 | Tracy B. Mckibben
Director
|
Grant | 126 | - |
| Jun 30, 2025 | Lionel L Nowell III
Director
|
Grant | 126 | - |
| Jun 30, 2025 | Victoria J Reich
Director
|
Grant | 126 | - |
| Jun 30, 2025 | Suzanne M. Vautrinot
Director
|
Grant | 126 | - |
| Jun 30, 2025 | John J Zillmer
Director
|
Grant | 126 | - |
| Jun 12, 2025 | Victoria J Reich
Director
|
Sell | 1.3K | $352.3K |
| Jun 12, 2025 | Victoria J Reich
Director
|
Option | 1.3K | $149.6K |
| May 19, 2025 | Gregory B Cook
Officer
|
Grant | 65 | - |
| May 15, 2025 | Gregory B Cook
Officer
|
Sell | 2.2K | $565.2K |
| May 15, 2025 | Gregory B Cook
Officer
|
Option | 2.2K | $263.0K |
| May 7, 2025 | Nicholas J Alfano
Officer
|
Sell | 9.9K | $2.5M |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 16, 2026.